P-glycoprotein, lung resistance-related protein and multidrug resistance associated protein in de novo acute non-lymphocytic leukaemias: Biological and clinical implications

British Journal of Haematology

Volumn 104, Issue 2, 1999, Pages 328-335

  Michieli, Mariagrazia ^a   Damiani, Daniela ^a   Ermacora, Anna ^a   Masolini, Paola ^a   Raspadori, Donatella ^c   Visani, Giuseppe ^b   Scheper, R J ^d   Baccarani, Michele ^a  

^a UNIVERSITY HOSPITAL OF UDINE   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Acute leukaemia; Lung resistance related protein; Multidrug resistance associated protein; P glycoprotein

Indexed keywords

CYTARABINE; GLYCOPROTEIN P; IDARUBICIN; LUNG RESISTANCE PROTEIN; MITOXANTRONE; MULTIDRUG RESISTANCE PROTEIN;

ACUTE NONLYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; FEMALE; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CHROMOSOME ABERRATIONS; FEMALE; GENES, MDR; HUMANS; KARYOTYPING; LEUKEMIA, NONLYMPHOCYTIC, ACUTE; MALE; MIDDLE AGED; NEOPLASM PROTEINS; P-GLYCOPROTEIN; PROGNOSIS; SURVIVAL RATE; VAULT RIBONUCLEOPROTEIN PARTICLES;

EID: 0032911283     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01172.x     Document Type: Article

References (47)

1. Berman, E., Adams, M., Duigou-Osterndorf, R., Godfrey, L., Clarkson, B. & Andreeff, M. (1991) Effect of tamoxifen on cell lines displaying the multidrug-resistant phenotype. Blood, 77, 818-825.
2. Bennet, J., Catovsky, D., Daniel, M., Flandrin, G., Galton, D., Gralnick, H. & Sultan, C. (1985) Proposed revised criteria for the classification of acute myeloid leukemia. Annals of Internal Medicine, 103, 626-629.
3. Borg, A.G., Burgess, R., Scheper, R.J. & Liu Yin, J.A.L. (1996) Clinical significance of LRP expression in acute myeloid leukaemia (AML). (Abstract). British Journal of Haematology, 93, (Suppl. 2), 348, abs. 1318.
4. Campos, L., Guyotat, D., Archimbaud, E., Calmard-Oriol, P., Tsurruo, T., Troncy, J., Treille, D. & Fiere, D. (1992) Clinical significance of multidrug resistance P-glycoprotein expression on acute non-lymphoblastic leukemia cells at diagnosis. Blood, 79, 473-476.
5. Chin, J.E., Soffir, R., Noonan, K.E., Choi, K. & Roninson, I.B. (1989) Structure and expression of the human MDR (P-glycoprotein) gene family. Molecular and Cellular Biology, 9, 3808-3820.
6. Cole, S.P.C., Bhardwaj, G., Gerlach, J.H., Mackie, J.K., Grant, C.E., Almquist, K.C., Stewart, A.J., Kurz, E.U., Duncan, A.M.V. & Deeley, R.G. (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science, 258, 1650-1654.
7. Cox, D.R. (1970) The Analysis of Binary Data. Chapman & Hall, London.
8. Damiani, D., Michieli, M., Ermacora, A., Candoni, A., Raspadori, D., Geromin, A., Stocchi, R., Grimaz, S., Masolini, P., Michelutti, A., Schper, R.J. & Baccarani, M. (1998) P-glycoprotein (PGP), and not lung resistance-related protein (LRP), is a negative prognostic factor in secondary leukemias. Haematologica, 83, 290-297.
9. Damiani, D., Michieli, M., Michelutti, A., Fanin, R., Russo, D. & Baccarani, M. (1995) P170 glycoprotein expression and impaired anthracycline retention in chronic myeloid leukaemia. Leukemia and Lymphoma, 17, 289-294.
10. Flens, M.J., Izquierdo, M.A., Scheffer, G.L., Fritz, J.M., Meijer, J.L.M., Scheper, R.J. & Zaman, G.J.R. (1994) Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies. Cancer Research, 54, 4557-4563.
11. Filipits, M., Pohl, G., Stranzl, T., Suchomel, R.W., Scheper, R.J., Jäger, U., Geissler, K., Lechner, K. & Pirker, R. (1998) Expression of the lung resistance protein predicts poor outcome in de novo acute myeloid leukemia. Blood, 91, 1508-1513.
12. Goasguen, J.E., Dossot, J.M., Fardel, O., Le Mee, F., Le Gall, E., Leblay, R., Le Prise, P.Y., Chaperon, J. & Fauchet, R. (1993) Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of the novo acute lymphoblastic leukemia: prognostic implications. Blood, 81, 2394-2398.
13. Guerci, A., Merlin, J.L., Missoum, N., Feldman, L., Marchal, S., Witz, F., Rose, C. & Guerci, O. (1995) Predictive value for treatment outcome in acute myeloid leukemia of cellular daunorubicin accumulation and P-glycoprotein expression simultaneously determined by flow cytometry. Blood, 85, 2147-2153.
14. Hart, S.M., Ganeshaguru, K., Hoffbrand, A.V., Prentice, H.G. & Mehta, A.B. (1994) Expression of the multidrug resistance-associated protein (MRP) in acute leukaemia. Leukemia 8, 2163-2168.
15. Hart, S.M., Ganeshaguru, K., Scheper, R.J., Hoffbrand, A.V. & Mehta, A.B. (1995) Expression of the human major vault protein LRP in hematological malignancy. (Abstract). Blood, 86, (Suppl. 1), 40a.
16. Ino, T., Miyazaki, H., Isogai, M., Nomura, T., Tsuzuki, M., Tsuruo, T., Ezaki, K. & Hirano, M. (1994) Expression of P-glycoprotein in de novo acute myelogenous leukemia at initial diagnosis: results of molecular and functional assays, and correlation with treatment outcome. Leukemia, 8, 1492-1499.
17. Izquierdo, M.A., Scheffer, G.L., Flens, M.J., Schroeinejers, A.B., van der Valk, P. & Scheper, R.J. (1996a) Major vault protein LRP-related multidrug resistance. European Journal of Cancer, 32A, 979-984.
18. Izquierdo, M.A., Shoemaker, R.H., Flens, M.J., Scheffer, G.L., Wu, L., Prather, T.R. & Scheper, R.J. (1996b) Overlapping phenotypes of MDR among panels of human cancer cell line. International Journal of Cancer, 65, 230-237.
19. Kaplan, E.L. & Meier, P. (1958) Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457-481.
20. Kuiper, C.M., Broxterman, H.J., Baas, F., Schuurhuis, G.J., Haisman, H.J., Scheffer, G.L., Lankelma, J. & Pinedo, H.M. (1990) Drug transport variants without P-glycoprotein overexpression from a human squamous lung cancer cell line after selection with doxorubicin. Journal of Cellular Pharmacology, 1, 35-41.
21. Kruh, G.D., Chan, A., Myers, K., Gaughan, K., Miki, T. & Aaronson, S.A. (1994) Expression complementary DNA library transfer establishes mrp as a MDR gene. Cancer Research, 54, 1649-1652.
22. Legrand, O., Simonin, G., Zittour, R. & Marie, J.P. Comparison of MDR1, MRP and LRP expression in vitro drug and in vivo response to treatment in fresh blast cells from adult acute leukemia patients. (Abstract). Blood, 90, (Suppl. 1), 180a.
23. Leith, C.P., Kopecky, K.J., Chen, I.M., Slovac, M., Head, D.R., Weick, J., Applepaund, F.R. & Willman, C.L. (1997) Frequency and clinical significance of expression of the multidrug resistance proteins, MDR1, MRP1 and LRP in acute myeloid leukemia patents less than 65 years old. (Abstract). Blood, 90, (Suppl. 1), 389a.
24. List, A.F., Spier, C.S., Grogan, T.M., Johnson, C., Roe, D.J., Greer, J.P., Wolff, S.N., Broxterman, H.J., Scheffer, G.L., Scheper, R.J. & Dalton, W.S. (1996) Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia. Blood, 87, 2464-2469.
25. Luck, C.K. & Tannock, I.F. (1989) Flow cytometry analysis of doxorubicin accumulation in cells from human and rodent cell lines. Journal of the National Cancer Institute, 81, 55-59.
26. Michieli, M., Damiani, D., Ermacora, A., Raspadori, D., Michelutti, A., Grimaz, S., Fanin, R., Russo, D., Lauria, F., Masolini, P. & Baccarani, M. (1997) P-glycoprotein (PGP) and lung resistance-related protein (LRP) expression and function in leukaemic blast cells. British Journal of Haematology, 96, 356-365.
27. Michieli, M., Damiani, D., Geromin, A., Michelutti, A., Fanin, R., Raspadori, D., Russo, D., Visani, G., Dinota, A., Pileri, S., Tsuruo, T., Grandi, M., Baccarani, M. & Tura, S. (1992) Overexpression of multidrug resistance-associated p170-glycoprotein in acute non-lymphocytic leukemia. European Journal of Hematology, 48, 87-92.
28. Michieli, M., Damiani, D., Michelutti, A., Grimaz, S., Geromin, A., Fanin, R., Russo, D., Masolini, P. & Baccarani, M. (1996) Screening for multidrug resistance in leukemia: cell reactivity to MRK-16 correlates with anthracycline retention and sensitivity of leukemic cells. Leukemia and Lymphoma, 18, 179-184.
29. Michieli, M., Michelutti, A., Damiani, D., Pipan, C., Raspadori, D., Lauria, F. & Baccarani, M. (1993) A comparative analysis of the sensitivity of multidrug resistant (MDR) and non-MDR cells to different anthracycline derivatives. Leukemia and Lymphoma, 9, 255-264.
30. Peto, R., Pike, M.C., Armitage, P., Breslow, N.E., Cox, D.R., Howard, S.V., Mantel, N., McPherson, K., Peto, J. & Smith, P.G. (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. British Journal of Cancer, 35, 1-39.
31. Pileri, S., Sabattini, E., Falini, B., Tazzari, P.L., Gherlinzoni, F., Michieli, M.G., Damiani, D., Zucchini, L., Gobbi, M., Tsuruo, T. & Baccarani, M. (1991) Immunohistochemical detection of the multidrug transport protein P170 in human normal tissues and malignant lymphomas. Histopathology, 19, 131-140.
32. Ross, D.D., Doyle, L.A., Schiffer, C.A., Lee, E.J., Grant, C.E., Cole, S.P.C., Deeley, R.G., Yang, W. & Tong, Y. (1996) Expression of multidrug resistance-associated protein (MRP) mRNA in blast cells from acute myeloid leukemia (AML) patients. Leukemia, 10, 48-55.
33. Sato, H., Preisler, H., Day, A., Raza, A., Larson, R., Browman, G., Goldberg, J., Vogler, R., Grunwald, H., Gottlieb, A., Benett, J., Gottesman, M. & Pastan, I. (1990) MDR1 transcript levels as an indication of resistant disease in acute myelogenous leukaemia. British Journal of Haematology, 73, 340-345.
34. Scheffer, G.L., Wijngaard, P.L.J., Flens, M.J., Izquierdo, M.A., Slovak, M.L., Pinedo, H.M., Meijer, C.J.L.M., Clevers, H.C. & Scheper, R.J. (1995) The drug resistance-related protein LRP is the human major vault protein. Nature Medicine, 1, 578-582.
35. Scheper, R.J., Broxterman, H.J., Scheffer, G.L., Kaaijk, P., Dalton, W.S., van Heijningen, T.H.M., van Kalken, G.K., Slovak, M.L., de Vries, E.G.E., van der Valk, P., Meijer, C.J.L.M. & Pinedo, H.M. (1993) Overexpression of a Mr 110-000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Research, 53, 1475-1479.
36. Shao, Y., de Giuli, R., Wyler, B., Lehnert, M. (1995) Overexpression of MDR1/P-glycoprotein and MRP but not LRP is mutually exclusive in multidrug resistant human myeloma cells selected with doxorubicin. Proceedings of the American Association of Cancer Research, 36, 337.
37. Slovak, M.L., Ho, J.P., Bhardwaj, G., Kurz, E.U., Deeley, R.G. & Cole, S.P.C. (1993) Localization of a novel multidrug resistance-associated gene in the HT1080/DR4 and H69AR human tumor cell lines. Cancer Research, 53, 3221-3225.
38. Slovak, M.L., Ho, J.P., Cole, S.P., Deeley, R.G., Greenherger, L., de Vries, E.G.E., Broxterman, H.J., Scheffer, G.L. & Scheper, R.J. (1995) The LRP gene encoding a major vault protein associated with drug resistance maps proximal to MRP on chromosome 16: evidence that chromosome breakage plays a key role in MRP or LRP gene amplification. Cancer Research, 55, 4214-4219.
39. Sonneveld, P., van Rens, G.L., Boevere, M.J., Schoester, M., Scheper, R. & Smit, E. (1995) Molecular and functional analsyis of a multidrug resistance phenotypes in poor-risk AML with - 7/7Q-karyotype. (Abstract). Blood, 86, (Suppl. 1), 517a.
40. Te Boekhorst, P.A.W., Löwenberg, B., van Kapel, J., Nooter, K. & Sonneveld, P. (1995) Multidrug resistant cells with high proliferative capacity determine response to therapy in acute myeloid leukemia. Leukemia, 9, 1025-1031.
41. Tiirikainen, M.I., Elonen, E., Ruutu, T., Jansson, S.E. & Krusius, T. (1993) Clinical significance of P-glycoprotein expression in acute leukaemia as analysed by immunocytochemistry. Eurapean Journal of Haematology, 50, 279-285.
42. Tsuruo, T. (1988) Mechanisms of muItidrug resistance and implications for therapy. Japanese Journal of Cancer Research, 79, 285-296.
43. 4 sublines with increasing adriamycin resistance. International Journal of Cancer, 61, 375-380.
44. Weinstein, R.S., Kuszak, J.R., Kluskens, L.F. & Coon, J.S. (1990) P-glycoprotein in pathology: the multidrug resistance gene family in humans. Human Pathology, 21, 34-48.
45. Wood, P., Burgess, R., MacGregor, A. & Yin, J.A.L. (1994) P-glycoprotein expression on acute myeloid leukaemia blast cells at diagnosis predicts response to chemotherapy and survival. British Journal of Haematology, 87, 509-513.
46. Zhou D.C., Zittoun, R. & Marie, J.P. (1995) Expression of multidrug resistance-associated protein (MRP) and multidrug resistance (MDR1) genes in acute myeloid leukemia. Leukemia, 9, 1661-1666.
47. Zöchbauer, S., Gsur, A., Brunner, R., Kyrle, P.A., Lechner, K. & Pirker, R. (1994) P-glycoprotein expression as unfavorable prognostic factor in acute myeloid leukemia. Leukemia, 8, 974-977.